Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders

Human Molecular Genetics

Volumn 23, Issue 6, 2014, Pages 1563-1578

  Zhu, Li ^a   Wang, Xiaoming ^a   Li, Xin Lei ^a   Towers, Aaron ^a   Cao, Xinyu ^a   Wang, Ping ^a   Bowman, Rachel ^a   Yang, Hyuna ^a   Goldstein, Jennifer ^a   Li, Yi Ju ^a   Jiang, Yong Hui ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE SPLICING; BRAIN; CELL LINE, TUMOR; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; EXONS; GENE EXPRESSION REGULATION; GENE-ENVIRONMENT INTERACTION; HEK293 CELLS; HUMANS; NERVE TISSUE PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS;

EID: 84894535118     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt547     Document Type: Article

References (69)

1. Abrahams, B.S. and Geschwind, D.H. (2008) Advances in autism genetics: on the threshold of a new neurobiology. Nat. Rev. Genet, 9, 341-355.
2. Schaaf, C.P. and Zoghbi, H.Y. (2011) Solving the autism puzzle a few pieces at a time. Neuron, 70, 806-808.
3. State, M.W. and Levitt, P. (2011) The conundrums of understanding genetic risks for autism spectrum disorders. Nat. Neurosci., 14, 1499-1506.
4. Devlin, B. and Scherer, S.W. (2012) Genetic architecture in autism spectrum disorder. Curr. Opin. Genet. Dev., 22, 229-237.
5. Newschaffer, C.J., Croen, L.A., Daniels, J., Giarelli, E., Grether, J.K., Levy, S.E., Mandell, D.S., Miller, L.A., Pinto-Martin, J., Reaven, J. et al. (2007) The epidemiology of autism spectrum disorders. Annu. Rev. Public Health, 28, 235-258.
6. CDC (2012) Prevalence of autism spectrum disorders - autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR Surveill. Summ., 61, 1-19.
7. Jiang, Y.H., Sahoo, T., Michaelis, R.C., Bercovich, D., Bressler, J., Kashork, C.D., Liu, Q., Shaffer, L.G., Schroer, R.J., Stockton, D.W. et al. (2004) A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am. J. Med. Genet. A, 131, 1-10.
8. Lasalle, J.M. (2013) Epigenomic strategies at the interface of genetic and environmental risk factors for autism. J. Hum. Genet. 58, 396-401.
9. Wong, C.C., Meaburn, E.L., Ronald, A., Price, T.S., Jeffries, A.R., Schalkwyk, L.C., Plomin, R. and Mill, J. (2013) Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits. Mol. Psychiatry.doi:10.1038/mp.2013.41.
10. Petronis, A. (2010) Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature, 465, 721-727.
11. Nguyen, A., Rauch, T.A., Pfeifer, G.P. and Hu, V.W. (2010) Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J., 24, 3036-3051.
12. Gregory, S.G., Connelly, J.J., Towers, A.J., Johnson, J., Biscocho, D., Markunas, C.A., Lintas, C., Abramson, R.K., Wright, H.H., Ellis, P. et al. (2009) Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med., 7, 62.
13. Betancur, C. (2011) Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res., 1380, 42-77.
14. Bourgeron, T. (2009) A synaptic trek to autism. Curr. Opin. Neurobiol., 19, 231-234.
15. Grabrucker, A.M., Schmeisser, M.J., Schoen, M. and Boeckers, T.M. (2011) Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies. Trends Cell Biol., 21, 594-603.
16. Jiang, Y.H. and Ehlers, M.D. (2013) Modeling autism by SHANK gene mutations in mice. Neuron, 78, 8-27.
17. Phelan, K. (2007) Roberta, A., Pagon, E.-i.-c., Bird, T. C., Dolan, C. R. and Stephens, K. (eds), In Gene Reviews. Internet, Seattle.
18. Durand, C.M., Betancur, C., Boeckers, T.M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I.C., Anckarsater, H. et al. (2007) Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet., 39, 25-27.
19. Moessner, R., Marshall, C.R., Sutcliffe, J.S., Skaug, J., Pinto, D., Vincent, J., Zwaigenbaum, L., Fernandez, B., Roberts, W., Szatmari, P. et al. (2007) Contribution of SHANK3 mutations to autism spectrum disorder. Am. J. Hum. Genet., 81, 1289-1297.
20. Boccuto, L., Lauri, M., Sarasua, S.M., Skinner, C.D., Buccella, D., Dwivedi, A., Orteschi, D., Collins, J.S., Zollino, M., Visconti, P. et al. (2012) Prevalence ofSHANK3variants in patients with different subtypes of autism spectrum disorders. Eur. J. Hum. Genet., 21, 310-316.
21. Gauthier, J., Champagne, N., Lafreniere, R.G., Xiong, L., Spiegelman, D., Brustein, E., Lapointe, M., Peng, H., Cote, M., Noreau, A. et al. (2010) De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc. Natl. Acad. Sci. USA, 107, 7863-7868.
22. Beri, S., Tonna, N., Menozzi, G., Bonaglia, M.C., Sala, C. and Giorda, R. (2007) DNA methylation regulates tissue-specific expression of Shank3. J. Neurochem., 101, 1380-1391.
23. Ching, T.T., Maunakea, A.K., Jun, P., Hong, C., Zardo, G., Pinkel, D., Albertson, D.G., Fridlyand, J., Mao, J.H., Shchors, K. et al. (2005) Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3. Nat. Genet., 37, 645-651.
24. Maunakea, A.K., Nagarajan, R.P., Bilenky, M., Ballinger, T.J., D'Souza, C., Fouse, S.D., Johnson, B.E., Hong, C., Nielsen, C., Zhao, Y. et al. (2010) Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature, 466, 253-257.
25. Bozdagi, O., Sakurai, T., Papapetrou, D., Wang, X., Dickstein, D.L., Takahashi, N., Kajiwara, Y., Yang, M., Katz, A.M., Scattoni, M.L. et al. (2010) Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol. Autism, 1, 15.
26. Peca, J., Feliciano, C., Ting, J.T., Wang, W., Wells, M.F., Venkatraman, T.N., Lascola, C.D., Fu, Z. and Feng, G. (2011) Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature, 472, 437-442.
27. Schmeisser, M.J., Ey, E., Wegener, S., Bockmann, J., Stempel, A.V., Kuebler, A., Janssen, A.L., Udvardi, P.T., Shiban, E., Spilker, C. et al. (2012) Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature, 486, 256-260.
28. Wang, X., McCoy, P.A., Rodriguiz, R.M., Pan, Y., Je, H.S., Roberts, A.C., Kim, C.J., Berrios, J., Colvin, J.S., Bousquet-Moore, D. et al. (2011) Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum. Mol. Genet., 20, 3093-3108.
29. Lord, C., Pickles, A., McLennan, J., Rutter, M., Bregman, J., Folstein, S., Fombonne, E., Leboyer, M. and Minshew, N. (1997) Diagnosing autism: analyses of data from the autism diagnostic interview. J. Autism Dev. Disord., 27, 501-517.
30. Phelan, M.C. (2008) Deletion 22q13.3 syndrome. Orphanet. J. Rare Dis., 3, 14.
31. Fatemi, S.H., Aldinger, K.A., Ashwood, P., Bauman, M.L., Blaha, C.D., Blatt, G.J., Chauhan, A., Chauhan, V., Dager, S.R., Dickson, P.E. et al. (2012) Consensus paper: pathological role of the cerebellum in autism. Cerebellum, 11, 777-807.
32. Bauman, M.L. and Kemper, T.L. (2005) Neuroanatomic observations of the brain in autism: a review and future directions. Int. J. Dev. Neurosci., 23, 183-187.
33. Wilson, H.L., Wong, A.C., Shaw, S.R., Tse, W.Y., Stapleton, G.A., Phelan, M.C., Hu, S., Marshall, J. and McDermid, H.E. (2003) Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J. Med. Genet., 40, 575-584.
34. Courchesne, E., Pierce, K., Schumann, C.M., Redcay, E., Buckwalter, J.A., Kennedy, D.P. and Morgan, J. (2007) Mapping early brain development in autism. Neuron, 56, 399-413.
35. Amaral, D.G., Schumann, C.M. and Nordahl, C.W. (2008) Neuroanatomy of autism. Trends Neurosci., 31, 137-145.
36. Minshew, N.J. and Keller, T.A. (2010) The nature of brain dysfunction in autism: functional brain imaging studies. Curr. Opin. Neurol., 23, 124-130.
37. Philip, R.C., Dauvermann, M.R., Whalley, H.C., Baynham, K., Lawrie, S.M. and Stanfield, A.C. (2012) A systematic review and meta-analysis of the fMRI investigation of autism spectrum disorders. Neurosci. Biobehav. Rev., 36, 901-942.
38. Wintle, R.F., Lionel, A.C., Hu, P., Ginsberg, S.D., Pinto, D., Thiruvahindrapduram, B., Wei, J., Marshall, C.R., Pickett, J., Cook, E.H. et al. (2011) A genotype resource for postmortem brain samples from the autism tissue program. Autism Res, 4, 89-97.
39. Sutcliffe, J.S., Nakao, M., Christian, S., Orstavik, K.H., Tommerup, N., Ledbetter, D.H. and Beaudet, A.L. (1994) Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nat. Genet., 8, 52-58.
40. Shukla, S., Kavak, E., Gregory, M., Imashimizu, M., Shutinoski, B., Kashlev, M., Oberdoerffer, P., Sandberg, R. and Oberdoerffer, S. (2011) CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature, 479, 74-79.
41. Patel, D.J. and Wang, Z. (2013) Readout of epigenetic modifications. Annu. Rev. Biochem., 82, 81-118.
42. Gauthier, J., Spiegelman, D., Piton, A., Lafreniere, R.G., Laurent, S., St-Onge, J., Lapointe, L., Hamdan, F.F., Cossette, P., Mottron, L. et al. (2009) Novel de novo SHANK3 mutation in autistic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet., 150B, 421-424.
43. Buxbaum, J.D., Daly, M.J., Devlin, B., Lehner, T., Roeder, K. and State, M.W. (2012) The autism sequencing consortium: large-scale, high-throughput sequencing in autism spectrum disorders. Neuron, 76, 1052-1056.
44. Deaton, A.M., Webb, S., Kerr, A.R., Illingworth, R.S., Guy, J., Andrews, R. and Bird, A. (2011) Cell type-specific DNA methylation at intragenic CpG islands in the immune system. Genome Res., 21, 1074-1086.
45. Nagarajan, R.P., Hogart, A.R., Gwye, Y., Martin, M.R. and LaSalle, J.M. (2006) Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics, 1, e1-11.
46. Shulha, H.P., Cheung, I., Whittle, C., Wang, J., Virgil, D., Lin, C.L., Guo, Y., Lessard, A., Akbarian, S. and Weng, Z. (2012) Epigenetic signatures of autism: trimethylated H3K4 landscapes in prefrontal neurons. Arch. Gen. Psychiatry, 69, 314-324.
47. Reik, W., Dean, W. and Walter, J. (2001) Epigenetic reprogramming in mammalian development. Science, 293, 1089-1093.
48. Meaney, M.J. and Szyf, M. (2005) Environmental programming of stress responses throughDNAmethylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin. Neurosci., 7, 103-123.
49. Zhang, D., Cheng, L., Badner, J.A., Chen, C., Chen, Q., Luo, W., Craig, D.W., Redman, M., Gershon, E.S. and Liu, C. (2010) Genetic control of individual differences in gene-specific methylation in human brain. Am. J. Hum. Genet., 86, 411-419.
50. Jiang, Y., Tsai, T.F., Bressler, J. and Beaudet, A.L. (1998) Imprinting in Angelman and Prader-Willi syndromes. Curr. Opin. Genet. Dev., 8, 334-342.
51. Wolff, G.L., Kodell, R.L., Moore, S.R. and Cooney, C.A. (1998) Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J., 12, 949-957.
52. Waterland, R.A. and Jirtle, R.L. (2004) Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition, 20, 63-68.
53. Dolinoy, D.C., Weidman, J.R., Waterland, R.A. and Jirtle, R.L. (2006) Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ. Health Perspect., 114, 567-572.
54. Kirkbride, J.B., Susser, E., Kundakovic, M., Kresovich, J.K., Davey Smith, G. and Relton, C.L. (2012) Prenatal nutrition, epigenetics and schizophrenia risk: can we test causal effects? Epigenomics, 4, 303-315.
55. Lumey, L.H., Terry, M.B., Delgado-Cruzata, L., Liao, Y., Wang, Q., Susser, E., McKeague, I. and Santella, R.M. (2012) Adult global DNA methylation in relation to pre-natal nutrition. Int. J. Epidemiol., 41, 116-123.
56. Cook, E.H. Jr., Lindgren, V., Leventhal, B.L., Courchesne, R., Lincoln, A., Shulman, C., Lord, C. and Courchesne, E. (1997) Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am. J. Hum. Genet., 60, 928-934.
57. Stewart, L.R., Hall, A.L., Kang, S.H., Shaw, C.A. and Beaudet, A.L. (2011) High frequency of known copy number abnormalities and maternal duplication 15q11-q13 in patients with combined schizophrenia and epilepsy. BMC Med. Genet., 12, 154.
58. Ingason, A., Kirov, G., Giegling, I., Hansen, T., Isles, A.R., Jakobsen, K.D., Kristinsson, K.T., le Roux, L., Gustafsson, O., Craddock, N. et al. (2011) Maternally derived microduplications at 15q11-q13: implication of imprinted genes in psychotic illness. Am. J. Psychiatry, 168, 408-417.
59. Piard, J., Philippe, C., Marvier, M., Beneteau, C., Roth, V., Valduga, M., Beri, M., Bonnet, C., Gregoire, M.J., Jonveaux, P. et al. (2010) Clinical and molecular characterization of a large family with an interstitial 15q11q13 duplication. Am. J. Med. Genet. A, 152A, 1933-1941.
60. Marini, C., Cecconi, A., Contini, E., Pantaleo, M., Metitieri, T., Guarducci, S., Giglio, S., Guerrini, R. and Genuardi, M. (2013) Clinical and genetic study of a family with a paternally inherited 15q11-q13 duplication. Am. J. Med. Genet. A, 161, 1459-1464.
61. Hogart, A., Wu, D., LaSalle, J.M. and Schanen, N.C. (2010)The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13. Neurobiol. Dis., 38, 181-191.
62. Sarasua, S.M., Dwivedi, A., Boccuto, L., Rollins, J.D., Chen, C.F., Rogers, R.C., Phelan, K., Dupont, B.R. and Collins, J.S. (2011) Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome). J. Med. Genet., 48, 761-766.
63. Bonaglia, M.C., Giorda, R., Beri, S., De Agostini, C., Novara, F., Fichera, M., Grillo, L., Galesi, O., Vetro, A., Ciccone, R. et al. (2011) Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan/McDermid syndrome. PLoS Genet., 7, e1002173.
64. Dhar, S.U., del Gaudio, D., German, J.R., Peters, S.U., Ou, Z., Bader, P.I., Berg, J.S., Blazo, M., Brown, C.W., Graham, B.H. et al. (2010) 22q13.3 deletion syndrome: clinical and molecular analysis using array CGH. Am. J. Med. Genet. A, 152A, 573-581.
65. Leblond, S., Heinrich, J., Delorme, R., Proepper, C., Betancur, C., Huguet, G., Konyukh, M., Chaste, P., Ey, E., Rastam, M. et al. (2012) Genetic and functional analyses of SHANK2 mutations suggest a multiple Hit model of autism spectrum disorders. PLoS Genet., 8, e1002521.
66. Girirajan, S., Rosenfeld, J.A., Cooper, G.M., Antonacci, F., Siswara, P., Itsara, A., Vives, L., Walsh, T., McCarthy, S.E., Baker, C. et al. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat. Genet., 42, 203-209.
67. Deaton, A.M. and Bird, A. (2011) Cpg islands and the regulation of transcription. Genes Dev., 25, 1010-1022.
68. Chodavarapu, R.K., Feng, S., Bernatavichute, Y.V., Chen, P.Y., Stroud, H., Yu, Y., Hetzel, J.A., Kuo, F., Kim, J., Cokus, S.J. et al. (2010) Relationship between nucleosome positioning and DNA methylation. Nature, 466, 388-392.
69. Luco, R.F., Allo, M., Schor, I.E., Kornblihtt, A.R. and Misteli, T. (2011) Epigenetics in alternative pre-mRNA splicing. Cell, 144, 16-26.